Gene Amplification Gives Acinetobacter baumannii a Foothold in the Host, but at a Cost

Researchers have found that ISAba1-mediated amplification of the crp-osmC gene cluster boosts Acinetobacter baumannii's fitness in host environments, revealing a trade-off with antibiotic resistance that could reshape treatment strategies.

Chicago Metrowire Staff
••Healthcare
Gene Amplification Gives Acinetobacter baumannii a Foothold in the Host, but at a Cost

Acinetobacter baumannii is a leading cause of hospital-acquired infections, notorious for its multidrug resistance and ability to persist on surfaces and in patients. New research led by Yuqin Song and Jie Feng at the Institute of Microbiology, Chinese Academy of Sciences, has uncovered a genetic mechanism that helps the pathogen thrive inside a host, and it comes with an unexpected twist that may influence how clinicians approach treatment.

The study, published in mLife, analyzed thousands of A. baumannii genomes and found that the insertion sequence ISAba1 frequently drives amplification of a gene cluster called crp-osmC. This amplification, which the researchers designated composite transposon Tn7691, was strongly associated with the globally prevalent high-risk ST2 lineage. When the team experimentally increased the copy number of crp-osmC, the bacteria showed improved growth, a competitive edge in co-culture, and enhanced survival in mouse serum. More importantly, the amplified strains colonized mouse lungs and intestines more effectively, indicating a direct role in host adaptation.

Transcriptomic analysis revealed that the amplification ramps up genes involved in phenylalanine metabolism, siderophore biosynthesis, and sulfur metabolism, likely helping the bacteria acquire nutrients in the nutrient-poor environment of a host. The researchers also showed that the CRP protein retains its DNA-binding activity and directly binds the promoter of a siderophore-associated gene cluster, supporting a regulatory role in iron acquisition.

The finding matters because it expands the known function of insertion sequence-mediated gene amplification, which has traditionally been linked to antibiotic resistance. Here, the same process enhances host fitness, potentially explaining why certain lineages like ST2 are so successful in clinical settings. However, the advantage appears to come at a cost: the amplified strains formed less biofilm and were more susceptible to several antibiotics. This trade-off suggests that host adaptation and antibiotic resistance may pull in opposite directions, which could have implications for treatment strategies. If bacteria that are better at colonizing patients are also easier to kill with certain drugs, clinicians might exploit this vulnerability. Conversely, the reduced biofilm formation could affect persistence on medical equipment and within hospitals.

The work, supported by the National Key Research and Development Program of China and the National Natural Science Foundation of China, also highlights the value of large-scale genomic surveillance. By identifying Tn7691 and its association with high-risk clones, the researchers provide a potential marker for tracking the spread of strains that are particularly adept at causing infection. The full findings are available in mLife, and the study underscores the need to consider evolutionary trade-offs when designing interventions against this resilient pathogen.

Blockchain Registration

QR Code for Blockchain Registration